Beta Bionics, Inc. (BBNX)
17.71
+0.87
(+5.17%)
USD |
NASDAQ |
Oct 20, 16:00
17.71
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Gross Profit Margin (Quarterly) : 59.04% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.04% |
| March 31, 2026 | 59.50% |
| December 31, 2025 | 58.98% |
| September 30, 2025 | 55.48% |
| June 30, 2025 | 53.80% |
| March 31, 2025 | 50.86% |
| Date | Value |
|---|---|
| December 31, 2024 | 57.19% |
| September 30, 2024 | 53.36% |
| June 30, 2024 | 53.73% |
| March 31, 2024 | 55.68% |
| December 31, 2023 | 60.62% |
| September 30, 2023 | 39.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 78.09% |
| Intuitive Surgical, Inc. | 67.76% |
| Stryker Corp. | 66.14% |
| Zimmer Biomet Holdings, Inc. | 62.91% |
| Inspire Medical Systems, Inc. | 85.48% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.85% |
| Return on Assets | -23.01% |
| Return on Invested Capital | -25.22% |
| Profit Margin (Quarterly) | -73.10% |
| Operating Margin (Quarterly) | -79.90% |
| Return on Net Operating Assets | -126.5% |